Brief: Aura Biosciences FY Operating Income USD -96.116 Million
24/03/2025 20:01
Mar 24 (Reuters) - Aura Biosciences FY operating expenses USD 96.116 million. FY net income USD -86.919 million
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs